throbber

`CECIL
`3
`Texthook —
`
`
`22" Edition
`
`EDITED BY
`
`Lee Goldman, MD
`
`Julius R. Krevans Distinguished Professor and Chair
`Departmentof Medicine
`Associate Dean for Clinical Affairs
`University of California, San Francisco, School of Medicine
`San Francisco, California
`
`Jackson Professor of Clinical Medicine
`Harvard Medical School
`Chief, Medical Service
`Massachusetts General Hospital
`Boston, Massachusetts
`
`“ae —s al
`VOLUME 2
`
` *
`
`[seefa2
`
`i 1r
`
`R
`wh
`eye
`_
`
`,
`
`& anaft
`
`SAUNDERS
`|
`An Imprint of Elsevier
`
`
`MPI EXHIBIT 1129 PAGE 1
`
`

`

`k
`SAUNDERS
`An Imprintof Elsevier
`
`The Curtis Center
`Independence Square West
`Philadelphia, Pennsylvania 19106
`
`0-7216-9652-%
`CECIL TEXTBOOK OF MEDICINE, 22ND EDITION
`Sergi
`Single Volume
`0-8089=2
`Set (Vols. 1 and 2)
`1971, 1963, 1959, 1955, 1951, 1947,
`International Edition
`1979, 1975,
`A
`Copyright © 2004, 2000, 1996, 1991, 1988, 1982,
`1043, 1040, 1937, 1933, 1930, 1927, Elsevier Inc. All rights reserved,
`Copyright renewed 1991 by Paul Beeson.
`Copyright renewed 1979 by Russell L. Cecil and Robert F Been seek
`Copyright renewed 1987, 1975, 1971, 1965, 1961, 1958, 1955 by
`Els
`:
`r 11, “The Periodic
`Thefollowing chapters are in the public domain (except borrowedfiguresHi akbyscile Chanter 29,
`Health Examination,” by David Atkins; Chapter 16, “Immunization, atte i er ay ete hel Bistrais:
`“Pain,” by Mitchell B. Max; Chapter 34, “Complementary and Alternative Me Tae a a eeaoa:
`Chapter 55, “Heart Failure: Pathophysiology and Diagnosis,’ by Barry M. Mass a
`Pp
`Neo faaieebe
`Endocrine Tumors,” by Robert T. Jensen; Chapter 198, “Lung Cancer and Other
`Pu eet eee *
`York E. Miller; Chapter 224, “Wilson's Disease,” by Stephen G. Kaler; Chapter 257,
`inera a
`Homeostasis,” by StephenJ, Marx, Chapter 260, “The Parathyroid Glands, Peeee aah
`Hypocalcemia,” by Allen M. Spiegel; Chapter 272, “Mastocytosis,” by Dean D. Metca ie;
`: ae fi ieee
`“Introduction to Bacterial Disease,” by David A. Relman; Chapter 309, “Rheumatic Fever, by Alan L. Bisno;
`Chapter 314,“Infections Caused by Haemophilus Species," by Michael 5. Simberkoff, Chapter 317,
`“Diphtheria,” by Roland W.Sutter, Chapter 373, “Enteroviruses,” by Michael N. Oxman, Chapter 374,
`“Viral Gastroenteritis,” by Albert Z. Kapikian; Chapter 378, “Introduction to Mycoses,” by Carol A.
`Kauffman; Chapter 379, “Histoplasmosis,” by Carol A. Kauffman; Chapter 381, “Blastomycosis, by CarolA.
`Kauffman; Chapter 382, “Paracoccidioidomycosis,” by Carol A. Kauffman; Chapter 383, “Cryptococcosis,
`by Carol A. Kauffman; Chapter 384, “Sporotrichosis,” by Carol A. Kauffman; Chapter 385, “Candidiasis,” by
`Carol A, Kauffman; Chapter 394, “American Trypanosomiasis (Chagas’ Disease),” by Franklin A. Neva,
`
`Nopart ofthis publication may be reproduced or transmitted in any form or by any means,electronic or
`mechanical, including photocopying, recording, or any information storage and retrieval system, without
`permission in writing from the publisher.
`Permissions may be sought directly from Elsevier's Health Sciences Rights Department in Philadelphia,
`USA: phone: (+1) 215-238-7869; fax: (+1) 215-238-2239; e-mail: healthpermissions@elsevier.com. You may
`also complete your request online via the Elsevier homepage (www.elsevier.com) by selecting “Customer
`Support,” then “Obtaining Permissions.”
`
`Notice
`Medicine is an ever-changing field. Standard safety precautions mustbe followed, but as new research
`and clinical experience broaden our knowledge, changesin treatment and drug therapy become
`necessary or appropriate, Readers are advised to check the product information currently provided by
`the manufacturer of each drug to be administered to verify the recommended dose, the method and
`duration of administration, and contraindications.11 is the
`relying on experience and knowledgeofthe patient,
`to determine dosages and th
`mn
`:
`each individualpatient, Neither the Publishernor the editors assumegh responsibility for cen
`and/or damageto persons orpropertyarising from this publication,
`ee
`
`e best treat
`
`responsibility of the treating physician, The Publisher
`
`Library of Congress Cataloging-in-Publication Data
`Cecil textbook of medicine / edited by Lee Goldman, Dennis Ausiello—22nd ed
`p. ; cm.
`Includes bibliographicalrefere:
`ISBN 0-7216-9650-X
`aes Bia
`1. Internal medicine.
`1. Title: Textho Ik
`of
`1881-1965.
`Ill. Goldman,Lee, MD.
`1V Oe I. Cecil, Russell L. (Russell La Fayette),
`[DNLM:1, Medicine. WB 100 C3888 2004, |
`RC46.C423 2004
`616—de21
`
`ExecutivePublisher, Global Medicine: Kim Murphy
`Executive Director ofDevelopment; Lynne Gery
`Publishing Services Manager: Frank Polizzano
`Senior Project Manager: Robin E, Davis
`Vesiesiee DevelopmentalEditor:Joanie Milnes
`nterior Design: Katen O'Keefe Owens
`
`2003
`
`a
`
`Printed in theUnited States of America,
`‘astdigitisthe printnumber 9g. 7 65ai
`
`
`

`
`1129 PAGE2
`
`
`
`MPI EXHIBIT 1129 PAGE 2
`
`

`

`933] OBESITY
`
`Michael D. Jensen
`
`Chapter 233 Obesity|1339
`88cm or 35 inches for women) is considered an additional indica-
`tion of risk for overweight and obesity. This measure is primarily
`relevantto disease risk in overweight and class 1 obesity categories,
`however.
`In. overweight
`individuals, a large waist circumference
`changes therelative risk from “increased” (relative to someone with
`a normal BMI) to “high,” In class | obesity, a large waist circumfer-
`ence increases the risk of disease from “high” to “very high.” A large
`waist circumference does notaffect disease risk in those persons with
`class 2 or class 3 obesity,
`
`Prevalence
`
`
`
`sasees|g/BUORMINN
`
`ity is the most common nutritional disorder in the Unite
`Of,costing more that $100 billion per year in healthiest
`expenses. Most physicians do Notreceive specific training in the eval-
`‘ation and management of obesity despite the fact thai more than
`half the patients theyencounter are likely to be overweight or ohese.
`Although progress has been made in understanding the pathophysi-
`ology and treatment ofobesity, it nonetheless remainsa dificult disease
`to treat, The safest and mosteffective treatment approaches (lifestyle
`and behavior modification) are not those commonly employed by
`physicians.
`
`The numberof overweight and obese adults in the United States
`has increased dramatically over the past 20 years.It is estimated that
`approximately 60% ofadult Americansareeitheroverweightor obese.
`Approximately 60% of U.S. men and 51% of U.S. women are over-
`weightor obese. It should be noted, however, that a preater percent-
`age ofwomen are obese than men, whereas a largerpercentage ofmen
`are overweight than women. There are substantial differences in the
`prevalence of obesity by age, race, and socioeconomicstatus, The
`prevalenceof obesity in adults tends torise steadily from ages 20 to
`60 years but does notincrease and,in [act, begins to decrease in later
`years. It has been estimated that almost 75% of men aged 60 to 69
`years in the United States have a BMIofgreater than 25. Theincrease
`in mean BMI with age may not be as muchofa threat to population
`health as mightfirst be anticipated, Whileitis true that youngadults
`with BMIs in the lowerpart of the normal range havethe lowest mor-
`tality rates, this changes with age. The BMIassociated with the lowest
`mortality rates is actually at or somewhat above 25kg/m’ for
`those in their 60s and 70s. Clearly, weight recommendations for a
`given individual depend on whether adverse health consequences
`associated with obesity have developed.
`The differences in overweight and obesity between Alrican-
`Americans, Mexican-Americans, and European-Americans are not
`subtle. African-American women and Mexican-Americans of both
`sexes have the highestrates of overweight and obesity in the United
`States. Wheninterpreting these data, however, itis important to keep
`in mind that there is an inverse relaionship between socioeconomic
`status andobesity, especially among women. Women in lowersocio-
`economicclasses are much morelikely to be obese than thosein higher
`socioeconomic classes. This association reduces, but does not elim-
`inate, the racial differences in the prevalenceof obesity. Whether the
`remaining racial differences in the prevalence ofobesity are due to
`genetic, constitutional, or social factors not related to incomeis not
`yet clear.
`
`Definition
`The National Institutes of Health/NHLBI report entitled “Clinical
`Guidelines on the Identification, Evaluation and Treatment of
`Overweight and Obesity” provides clear, scientifically based defini-
`tions of overweight and obesity, Body mass index (BMI) is now the
`recommended means to categorize weightrelativeto height foradults.
`Body mass index is calculated asweight (kg) divided by height squared
`(m’). To calculate BMI using pounds andinches, the formula is mod-
`ified as follows: weight (pounds)/height(inches)? x 703. The weight
`classifications according to BMI are summarized in Table 233-1.
`Individuals whe are overweight (BMI 25.0 to 29.9) may or may not
`be overfat, Some men may be overweight becauseofincreased muscle
`mass, which isa straightforward clinicaljudgment. Although in general
`the risk ofdeveloping weight-related health problemsincreases with
`a BMIgreater than 25, the guidelines point outthat intervention or
`discussion of weight issues with the patient may not be necessary for
`overweight adults who are entirely healthy and/or are not overfat. On
`the other hand, some individuals in the BMI27 to 29,9 range develop
`serious metabolic complications ofobesity that could be expected to
`improve with weight loss. These individuals are candidates for more
`aggressive treatment, including pharmacotherapyif needed.
`The risk of comorbidities increases considerably once the BMI
`increases above 30, the level at which obesity is diagnosed. Obesity
`is divided into three classes, also depending upon BMI. Treatment
`approaches maydiffer for those who are overweight andfordifferent
`classes ofobesity. For example, current Food and Drug Administration
`(FDA) guidelines indicate that pharmacotherapycan be adjuncttreat-
`ment for any class of obesity, even if medical complications are not
`present. Although some would argue that treating obese patients
`without medical complications is a lowerpriority than treating those
`with medical complications, familiarity with the guidelines is impor-
`lant; supervisory agencies and third party payers use them to deter-
`mine whois eligible for treatment benefits. Extreme obesity (BMI
`In one sense,the etiology of obesity can be considered simplisti-
`>40) is one of the key features that would promptconsideration of a
`cally; if energy intake exceeds energy expenditure, and if lean body
`patient for bariatric surgery when medical treatments have failed.
`mass remains stable, body fat must increase. Unfortunately, obesity
`Patients with class 2 obesity (BMI 35.0 to 39.9) may be considered
`is a much more complex issue, There are significant genetic/const-
`lor bariatric surgery if medical treatments havefailed andif severe,
`tutional susceptibility aspects to obesity that are heavily influenced
`life-threatening complications are present,
`by environmentalfactors, Evidence from family studies and studies
`The use of BMIto define overweight and obesity is an improve-
`of twins strongly supports the concept that within a given environ-
`ment over previous ideal weight
`tables, which were based on
`ment, a significant portion of the variation in weightis genetic. That
`height/yeight percentiles of individuals applying for insurance. In
`said, however, the tremendous increase in the prevalence of obesity
`addition to using BMI, the NHLBI Guidelines recommendusing the
`in the UnitedStates overthelast several decades can hardly beascnibed
`Waist circumferences as anotheroffice assessment tool that can help
`to mass changes in human DNA.
`with the treatment decision making process. A “large” waist cireum-
`GENETICASPECTS. Thereis strong evidence fora hereditary tendency
`lerence (greater than 102.cm or 40 inches for men and greater than
`toward the regulation ofbody weight. Thesingle genedefects result-
`
`ing in obesity include a number ofclassic genetic syndromes such as
`
`Prader-Willi and Laurence-Moon-BiedL, Thereaderis referred to text-
`
`books on genetic disorders fora completelistand description ofthese
`
`conditions. More recently, extremely rare monogenicforms ofhuman
`
`obesity due to mutations in the leptin gene andleptin receptor gene
`
`have been described. Theresult is an actual or functional leptin defi-
`
`ciency,muchlike that seen in ob/ob or db/db mice, the animal models
`
`a heritedformsofhuman obesity
`due to mutations ofgenes that
`thatstimulatedthe discovery of leptin, There have also beenreports
`
`»pelite neuropeptide
`esis. Doubtless, reports ofsingle
`muilonsasocateihanaobesitywillcontinueloappeary
`
`
`r,
`theoverwhelming malovity of cases of human obesi
`‘hecombinationofpolygenic susceptibilitytraits and
`
`
`al conditions.—
`
`
`Etiology
`
`a
`
`MPI EXHIBIT 1129 PAGE 3
`
`

`

`i
`
`Weel
`
`-om’
`
`TT
`
`I
`
`i
`
`
`witycan ebroadlyeeane
`eredacta aedworkandtheaetiy.
`-
`nd spotls
`employ™ able that allow ONE 16 eal
`an itiesinclude widely asidual’s weightas Well ag
`4340|Chapter 233 Obesty A numberof environmental slips
`ci
`:
`ise (fitness
`rise act!
`.
`ed on ,‘ch they&?gage. Unfortunately
`e-like effects on body weight regula’
`Noneneten ing:
`ities of daily V 5giture bas’
`: ptible to obesity-related fe
`canis enigA
`inexertectedtohaveApts.
`can result in long-term, Bet
`i
`id
`the
`pe
`and the tendency to he susce
`1
`Qo ed rauon thaobesity and other health prob.
`period on subsequent weight and hea pas aeeaial ii caeeatl?
`. development exercise regularly doesnotappear
`undermutrition 11 the last trimester© PE a uit obesity
`Me ut ikely that a changeitt exercige
`ostnatal period results In @ decrease
`8 Ath rite
`5 i¢ causil
`the increase in obesity,
`fiafortunately, the low birth weight that is Se en ate
`eeNeesSekaasoInceeaseTh adulthood. In
`a hh ea) activity is contributing to the
`se tolerance, and
`ca
`’
`d
`sina
`E
`ercise component that |s
`ee“undernutrition limited to the first te Beeata
`“tr is likely the none*
`To the extent
`nancy1s associated with an increased probabi ity oat ae Sees
`,
`Oo
`expended in nonexercise activ.
`Other early “environmental”effectsare that infants of
`ia dash i
`measure the energy
`1
`ent physical activi
`xing.
`vious that emp See systems in i
`itis difficult to
`tend to be fatter than those of nondiabetic mothers, ae Ae
`diabetic mothers have a greater prevalence of ae whe ae i
`h it set
`more au
`t
`insdecreased ait Seeite data in this regard. One estj-
`5 to 19yearsold, independentoftheir mother’0) ear a a
`intrauterine exposure to the diabetic environmentak ee
`ace, there
`and 1992, energy expenditure
`TReats that
`pe 50 kcal/day. The additional
`increased risk ofdiabetes mellitusandobesity in the o spring. rt
`the issue ofthe genes versus the environmentas regards obest yan
`at work decreasedBY oece that timehave likely further reduced
`metabolic complications of obesity1s blurred in the intrauterine %
`changes in the wor pia
`se,

`‘itt
`perinatal time intervals. One ofthe striking and worrisome mse
`employment physical activily:
`exercise physical activity, the activi:
`of these metabolic effects is not only the long-term effects om the
`The pine! componentdifficult to measure. A paneobi
`individual's weight regulation and health, but the suggesuion that
`nesofdaily Nea eg.drive-through foodand banking,ec ators,
`these traits can be
`passed on to future generations,
`CONTRIBUTORS. Few wouldarguethat there have been
`Eatenbaie e-mail, on-lineshopping) havebeen introducedinto
`dramatic changes in the environment over the last 50 years. These
`remotesomenvironment. Each of these further reduces the energy
`changes promoted a reduction in the amountofphysicalactivity that
`De a xpend to get through the day. Again, there are few
`Americans undertake. In addition, alterations in the food supply
`ST ch of a change has actually occurred,
`have either increased or failed to allow the expected decrease in
`assess how mu
`u
`|
`i
`Secanola in daily walking tps and an increase in daily
`energy intake that would be needed to match the reduced energy
`tri
`ile
`ted,
`automobile trips has been documen
`:
`;
`;
`Perhaps because it is easier to assess, information as to how-dif-
`expenditure.
`;
`Food. A numberofenvironmentalfactors can influence food intake
`ferences in sedentary activity (television watching, video games,and
`(Table 233-2). Consuming energy-dense loods resultsin greater energy
`computer use) relate to obesity 1s more readily available. Thereis
`intake, because many adults respondto the volumeof food taken in
`rather than the energy contentoffood.This factor likely accounts for
`compelling evidence that more time spent in sedentary pursuits is
`the association between high-fat diets and excess body weight, many
`associatedwith anincreased risk ofoverweightand obesity,Thestrik-
`high-fat foods are also energy dense. When humans consumediets
`ing aspect to thesestudies is that the adverse effect of sedentary activ-
`that are high in fat but low in energy density, energy intake is not
`ities is independentof participation in traditional exercise activities.
`greater than would be expected based on the energy density of the
`Understanding the contributions of decreased work-related
`foods. Larger food portionsize has also been shownto increase food
`physicalactivity, decreased activity of daily living, and increases in
`intake. Given the trend in the United States to serve larger portions
`sedentary behavior can help the physician working with thepatient
`of food and beverage, this could be a contributing variable toward
`to uncoverpatterns that may relate to weight gain.
`obesity, Foodvarietycanalso affect energy intake. An increasedvariety
`In summary, there are clearly dramatic changes in Western envi-
`of entrees, sweets, snacks, and carbohydrates in the diet is associated
`eae that are conspiring to bring out tendencies toward obesity
`with an increaseinbody fatness and food intake. In contrast, an increase
`Eareiceconan
`in variety of vegetables available does notresult in an increased food
`intake and isnot associated with increased body fatness. Other factors
`obese patients identify vttch% riers a Baeae
`that may have broad population effects in the United States is the
`contributing to the proble
`aaah these environmental factors are
`reducedcosts of foodrelative to increased availability and palatabil-
`problem and develop plans for intervention.
`ity of foods.
`Several individual factors may also influence how the properties
`of food affect energy intake. Individuals vary with respect to their
`dietary restraint (the tendency to consciously limit food intake to
`Sey their feelings of hunger, or their disinhibition (the
`tendency to overeat opportunistically). {t has been proposed that
`interindividual differences in these factors may modify how [ood
`variety, portion size, and so on affect the eating profile.
`In additi
`to the environmentalinfluences on food consumption, there are ka
`the effects of the social context under which food is consumed and
`
`the emotional oftheindivistate
`
`staitified state of
`the individual. These effects are not yet well
`
`
`
`NutritionalDiseases
`
`
`
`:
`
`via ¢
`
`Che
`
`<
`capotemeta
`UNConscious processes:
`-
`lisi
`ary meansby 8enerallystored.astrigly®
`pri
`€S.
`:
`expands is to incr
`prim
`;
`[
`t
`hypertrophy). Thisensamountoffaeeadipose tissuemas
`owever, because ay Sess can store on|
`in eachcell (adipodre
`Sufficientfatis da ate is an upper lin Y a limited amount of
`preadipocytes oa eventually Agere the size offat cells:
`ue. Someadults sane stfomovascylay are recruited| ~
`Weightmorefra.’ *4!Pocytes m componentofadip
`isslowl,
`iSevidence thantPocyteh
`Ore readily than othe
`wlybutconti
`Ladip
`yperplasia than fromhyper
`invously
`he;
`u
`i
`suirpris:
`akanearnUTEOverAlthoughhsmay
`thoughtwe HennHelpate emphaa el §CtiVilies ina ee yey
`tu
`Wabout adipose 1 es
`that much of what Aance
`be incorrect.
`MPI EXHIBIT 1129 PAGE 4
`
`OSe tiss
`
`Ussue
`
`MPI EXHIBIT 1129 PAGE 4
`
`

`

`ENERGY INTAKE
`
`
`
`saspesiq(2U0nLINN
`
`Chapter 233 Obesity|1341
`st
`tin, a protein secreted by adipose ti
`corerows system effects on food intake aswella
`nantleptin resulted in
`a remarkable reduction in excessive hunger
`f cent snysiologicactions. led to the hopethat the problem
`andsignificantfat loss.
`In contrast, treatmentof overweightpatients
`:
`I
`5 onlation had been solved. The leptin-deficient animal
`with recombinant leptin did not show weightloss, despite achieving
`peak serum leptin concentrations greater than 30 times basallevels,
`ofweight
`the ob/ob mouse, ts severely obese, hyperphagic,
`Wey best sexually immature and has low ley
`In animals, leptin plays an important role in modulating the hypo-
`els of spon-
`fr
`gl
`On
`"
`s
`‘
`paabi2 dministering leptin to this
`thala mic-pituitary response to undernutrition and serves a protec-
`animal corrects all of
`tive function, Humanstudies are necessary to confirm this observation.
`ifs acntioned seea |
`esi
`Several ofthe observedeffects of exogenousleptin in ob/ob mice were
`ere”
`goesleptin play in human obesit
`y? Reports indicate
`hot observed in the single case of human leptin deficiency treated
`al role i individuals with increased body
`fat have high plasma
`with leptin. In summary, the discovery of leptin has been an impor-
`, julyrations therefore, leptin deficien
`V
`cy
`is not
`nobesity. Since the discoveryof ene, ont Siaehie
`tantadvancein understandingthe biology ofobesity; however, defects
`conte
`in leptin secretion or inherited defects in leptin action do not appear
`ring of consanguineous parents, have been found to
`to be the cause of even a tiny fraction of haman obesity.
`a peo waileptin deficiency; they were hyperphagic and severel
`veangenman leptin deficiency must be extremely rare, Some
`ecprac
`MNgenetic obesity (the db/db mouse andfa/fa rat) have
` nodels receptors, making them unresponsiveto leptin. These
`wv ep’ Mjsed the possibility that human obesity, rather than
`rat ion ofleptin deficiency, is a state ofleptin resistance
`ea ote human with a defective leptin receptor gene has
`pons4. itappears that peeae ae to leptin receptor
`;
`signaling genetic abnormalities)
`is extremely ra ;
`es (or 8iecied aboutthe physiology ofleptin in bones
`uch .ted in a diurnalfashion that appearsto be regulated by
`pti ={insulin and glucose on adipocytes. Leptin secretion can
`ed by30 to 40% with briefperiods of overfeeding (prior to
`esinbodySaaesseeby aveinHedges to
`rfeeding
`t
`result
`In significant changes in
`cage
`dsoa Thee rapid and substantial shifts in leptin pe
`pedSeetially accountfor a large portion ofthe variability in
`iatpeeFystrongrelationship between percentage ofbodyfat and
`iesetconcentrations. Whenbloodis collected undercarefully
`oralcircumstances, there is a very strong relationship between
`wo
`leptinconcentrations and percentageofbodyfat (Fig. 233-1).
`there is no difference in the relationship betweenleptin andper-
`wniage of body fat between women and men. Thus,the assertion
`dnt leptin resistance is present in women and in humanobesity is
`wi logical; if the normalbiologic Tesponse to increased bodyfatis
`
`messed leptin secretion, hyperleptinemia merely becomesadiffer-
`Table 233-3 ¢ SUGGESTEDBIOLOGICMODULATORS OF
`aidefinition offatness/obesity. Only whendeficiencyis present does
`FOOD INTAKE
`.
`isphysiology relate to the developmentofobesity.
`
`low or absentleptin results in extreme hunger.Treating patients
`PERIPHERALSIGNAL
`wih congenitalleptin deficiency with physiologic doses of recombi-
`Vagal
`ern
`vii
`(ey ry oY
`cholecystokinin
`==
`"
`tre il \|
`‘ApolipoproteinA-TV CONTRET
`owl
`Insulin —
`Y:
`TORT] n=) ane
`t
`Glucagon-likepeptide1
`aii a |
`Other glucagonrelated peptides (=)
`Leptin
`Pe
`ae ee
`fFwhealspon:
`rm.
`CLL TEPT ;
`dient
`onmam
`oeeta,a cola |
`
`oe 4 Ole
`iin
`vy mmc
`
`; & stimulatesfoodintake, _
`_
`. (-) inhibits foodintake._
`es al
`
`
`
`Muchhasbeen learned aboutthebiologicregulation offoodintake,
`mostly from the study of animal models. There area series of periph-
`eral “satiety” signals that act to inhibit further food intake at some
`pointduring meal consumption. Someofthe signals reach the brain
`via the vagus nerve and somevia the systemic circulation. Examples
`of the proposed humoral factors modulating appetite are listed in
`Table 233-3. Many of the compoundsare gut- or pancreas-derived
`hormones (cholecystokinin, glucagon-like peptide 1, insulin, and
`perhapsotherglucagon-related peptides or gut peptides) or peptides
`(apolipoprotein A-IV, secreted with chylomicrons). The signals are
`thoughtto be triggered both by mechanicalstimuli (e.g., the fullness
`of the stomach)and by the presence of nutrients in the jejunum and
`ileum. It has also been suggested that the drop in leptin concentra-
`tions atnight may allow the evolution ofhunger the followingmorning.
`The central nervous system regulation offood intake isalso better
`understood. A series of neuropeptides and monoamines have been
`identified that have either anabolic (increased food intake with or
`without decreased energy expenditure) or catabolic (decreased food
`intake with or without increased energy expenditure) properties. A
`list of these compounds is provided in Table 233-4. Understanding
`
`Table 233-4 » CENTRAL NERVOUSSYSTEM MO!
`
`OF ENERGY BALANCE
`
`|
`Nay,
`
`We?and eons relationship between serum leptin concentrations(log.
`by bled tromJenee®” of body fat in 43 lean and obesemen andwomen.
`ioofplasm Hensrud D, O'BrienPC, etal:Collectionand—
`ey thas, @]
`leptin concentration datainhumans,ObesRes
`‘AllTight,;2229 North American Association for theStudyof
`Teserved),
`,
`veal a a
`
`
`
`MPI EXHIBIT 1129 PAGE 5
`
`MPI EXHIBIT 1129 PAGE 5
`
`

`

`
`
`e
`
`expenditureof
`
`: Theen iit HuceaeweWork
`perv duct ol pecause therestimati0g the energyAe
`the am
`js not Tuc)
`vars
`1342.|Ghapter 233 Obes!)
`es
`for&, common tO Express
`very of thera-
`mayallowthe disco
`i
`anor
`:
`i
`3 whichis a multipleof
`the process of appetite regul
`inhibit or stimulate eitheranabolic
`valen’
`jdividual’s RMRis 1 keal/nn
`that will selectively
`peutic agents
`tem pathways:
`ich Highly trained athletescay
`fan in
`or catabolic central nervous Sys
`c
`oY ~xtendedperiods, =
`efor limited aete lower
`‘d als canon
`ctrel
`‘r
`refers to the ars
`number
`ry indiv!
`ork capac
`f oxygen that can Deco
`ount of
`endous variabilityin peak
`trem
`hat— beexpended. narsolely, related to howmuchang
`ed.
`;
`largely,
`DY
`work aa ol activity 5 pererstandingthecapacitylorplis
`Pertantconceplin
`ions) is the lactate
`tires
`Id.
`, aeeetandthusexerciseer ht rras the level at which exercise
`Tet
`hreshold can Sabie thatitcannot be maintainedmuch
`Thelactate t
`ee
`asamre—
`i
`hecomeso une
`an
`relates to the Pp er
`tise in
`lieThe biochemical SNeae observed. The lactate threshold
`.
`a
`bloodlactate ead 90% of an individual'speakworkSpasity
`may Tange Te lactate threshold closer mu her rates far lq
`*
`Training raises
`individuals to work at
`higne
`ily
`ki
`ger
`load, andthsese sedentary individuals Yeries
`eaeiatarequite low (sometimes oeoeents with a
`pinhe threshold can be even lower in obese P
`'ype
`an
`diabetes.
`_related activities) is commonlycon-
`Exercise (fitness- and sports ae
`sical activity thermogenesis.
`i
`main component of phy.
`;
`i
`Treeamountofenergycanbeexpendedinrelativelybrief
`periods in fit ©dividuals, most adults do not exercise at high levels
`cient duration to expenda large amount of energy. Thus,
`aniCTs solely on “exercise” as the main componentaf
`physical activity energy expenditure, it is important to consider the
`energy costs of nonexercise activily.
`;
`-
`Nonexercise activity thermogenesis (NEAT)is the caloric expense
`ofperformingall activities other than exercise. Therange ofobserved
`NEAT undercontrolled (metabolic chamber) conditions has been from
`less than 100 up to approximately 800 kcal/day. There is probably a
`muchwiderrangein free-living individuals. NEATts nota static com-
`ponentof daily energy expenditure. It has been shown that NEAT
`can increase in responseto increased food intake in an unconscious
`manner, In fact, modulation of NEAT can bea significantfactorthat
`acts to stabilize weight despite variations in food intake. Low levels
`of NEAT have been reported to predict future weight gain in
`some populations. There is virtually no information as to what the
`regulatory systems are that stimulate or inhibit NEAT.
`
`:
`
`
`
`NutritionalDiseases
`
`ENERGY EXPENDITURE
`es widely, from less than
`nditure in adults vari
`Dey ay nae than 5000 kcal/day, with larger, more P
`rey
`needs. Typical i
`400 keal/day to mor
`cally active ivdividuals havingthe greatest ene
`BY
`1) metabolic
`daily energy expenditure ts divided into resting (or basa
`and physical activity energy
`rate,
`the thermic effect of food,
`The basal metabolic rate (BMR)is the energy
`expenditure.
`veal
`ke, in the overnight postabsorplive
`diture of lying still at rest, awa
`"
`or to arising
`ed ae BMR fs measured after awakening but prt
`lic rate (RMR)is similarly defined but
`ed, The resting metabo
`For most seden-
`HaatSieastired before arising frombed.
`tion of energy
`tary adult Americans, the RMR represents the major por
`from less than 1200 to more
`expended during the day and may range
`ly 80%) of the BMR can be
`than 3000 keal/day, Most (approximately ©
`related to the amountoflean tissue an individual has.
`at the same
`Notall components oflean tissue consume oxygen
`relative rates. Visceral, or splanchnic bed, tissues account for approx-
`imately 25% ofresting metabolic rate buta much smaller propornon
`ofbody weight. The brain, which accounts for only a small percent
`ofbodyweight, accountsforalmost 15% ofRMR,Likewise, the heart
`(approximately 7%) and kidneys (approximately 5 to 10%) account
`for greater portions of resting energy needs than their relative con-
`tribution to body mass. In contrast, resting muscle makes up 40 to
`50% of lean tissue mass but accounts for only 25% of RMR. This
`changes dramatically with exercise, however; muscle can accountfor
`80 to 90% of energy expenditure during high-intensity exercise.
`Adipose tissue is a minor contributor to daily energy expenditure,
`consuming only approximately 3 kcal/kg/day.
`Although the vast majority of RMR can be accountedfor by the
`amountof lean tissue an individual has, there are also other, more
`subtle, influences on RMR.Age, gender (women haveslightly lower
`BMRs, even corrected for fat-free mass), and fat mass affect RMR.
`Slight changes in metabolic rate or BMR are observed during the
`menstrual cycle (luteal phase more than follicular phase). There is
`also evidence that heritable or family factors do influence BMR,
`accounting for as much as 10% ofinterindividual differences.
`There are both obligatory and facultative components to RMR.
`With an energy-restricted diet, significant reductions in BMRrelative
`to the amountof fat-free mass occur, Reductions in the production
`of triiodothyronine from thyroxineare thought to contribute to this
`phenomenon. Likewise, during brief periods of overfeeding, it has
`been found that RMR increases above that which would be expected
`for the amountof lean tissue present.
`_
`It has been proposed thatindividuals with BMRs lowerthan pre-
`dicted are atincreased risk offuture weightgain. Published data suggest
`thattherelative risk is small, and the clinical effort to identify such
`patients is not warranted. Measurementof BMR is sometimes help-
`fulin the evaluation ofpatients whoinsist they are unable to (oBe
`weight while following diets consisting of less than 1000 kcal/day,
`Almost withoutfail, their BMR is substantially greater than their
`reported food intake. This underscores the fact that most adults
`oh
`7
`Sat
`:
`;
`notoriously unreliable in assessing their own food intake.
`THERMIG EFFECT OF FOOD. Approxi
`!
`‘FOOD.
`Approximately 10% of the
`ooisexpendedin theprocessofdigestion,secretiontensa
`olism ee nutrients. There is significantinterindividual variabilit
`in
`thisvalue,rangingfrom alowofapproximately5% to ahigh ofssnhos
`imately 15% of meal calories that are “was
`_
`wasted” in the postprandial
`interval. The thermic effect of a mea
`lis related to the carbohydrate
`and protein caloric content of the m
`aas fat content haslittlestim-
`ulatory effect), Both obligatory an
`acullative components oft
`aay The obligatory ee
`thermiceffect of food have been i
`nents no doubtreflect the energy
`ergy
`costs of
`digestion, abs
`casetata, Approximately 60 to 70% ofthe peess
`5 obligatory, and the remaining 30 to 40% is facultative ther-
`Mogenesis, The twofactors though L to
`play a role in the facultative
`component of the thermic effect af food
`are the postprandial insulin
`pein ana activation of the 5
`ympathetic nervous system, The
`€ elleet of food j
`humans, but there ieee
`ower in insulin-resistani/o
`SereApr have been no reported links between tee
`Ogenesis and future obesity.
`
`Secondary Causes of Obesity
`MEDICATIONS. A growi
`Hg numberof medications cause weight gan
`in some or most of th
`
`i
`
`oaches,
`
`toateweony for the underlying condition.
`“m
`patientshave anunderlyingdisease
`can explain their obesi

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket